URISPAS SKF (Urispas 100 mg)
Generic Name: flavoxate
Pill imprint URISPAS SKF has been identified as Urispas 100 mg.
Urispas is used in the treatment of overactive bladder; urinary incontinence; dysuria and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Urispas 100 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about Urispas (flavoxate)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 2 Reviews – Add your own review/rating
- Drug class: urinary antispasmodics
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.